Methods and compositions for assessing crispr/cas-mediated disruption or excision and crispr/cas-induced recombination with an exogenous donor nucleic acid in vivo
AssigneeRegeneron Pharmaceuticals, Inc.
InventorsGuochun Gong, Charleen Hunt, Susannah Brydges, Suzanne Hartford, David Frendewey, Brian Zambrowicz, Andrew J. Murphy
Life of this patent
Estimating the term…